Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Room 221

Department of Internal Medicine

University of Genoa

V.le Benedetto XV 6

Italy

Name/email consistency: high

Room 221, Department of Internal Medicine, University of Genoa, V.le Benedetto XV 6, Italy. 2006 - 2012
Department of Internal Medicine, Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy. 2010
Massachusetts Institute of Technology, Department of Biology, Center for Cancer Research, Cambridge, USA. 2005
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. 2005

Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. Soncini, D., Caffa, I., Patrone, F., Ballestrero, A., Nencioni, A. Curr. Cancer. Drug. Targets (2012) [Pubmed]
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression. Nencioni, A., Cea, M., Garuti, A., Passalacqua, M., Raffaghello, L., Soncini, D., Moran, E., Zoppoli, G., Pistoia, V., Patrone, F., Ballestrero, A. PLoS. ONE (2010) [Pubmed]
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. Nencioni, A., Garuti, A., Schwarzenberg, K., Cirmena, G., Dal Bello, G., Rocco, I., Barbieri, E., Brossart, P., Patrone, F., Ballestrero, A. Eur. J. Immunol. (2006) [Pubmed]
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Nencioni, A., Hua, F., Dillon, C.P., Yokoo, R., Scheiermann, C., Cardone, M.H., Barbieri, E., Rocco, I., Garuti, A., Wesselborg, S., Belka, C., Brossart, P., Patrone, F., Ballestrero, A. Blood (2005) [Pubmed]
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Nencioni, A., Wille, L., Dal Bello, G., Boy, D., Cirmena, G., Wesselborg, S., Belka, C., Brossart, P., Patrone, F., Ballestrero, A. Clin. Cancer Res. (2005) [Pubmed]